Commercialisation Officer, Faculty of Medicine

Ryhan Miah is a Commercialisation Officer within the Faculty of Medicine at Imperial College London, responsible for evaluating new inventions, managing IP protection, and driving collaboration between academics and industry partners. His work spans deep-tech innovation, sustainable chemical technologies and social enterprise engagement—advancing Imperial discoveries toward real-world impact through licensing and partnerships.

Ryhan holds an MChem in Chemistry with Medicinal Chemistry from Newcastle University and a Postgraduate Certificate in Intellectual Property from Bournemouth University. His combined scientific and IP background enables him to assess both technical merit and commercial potential, ensuring Imperial’s medical and scientific innovations reach global markets effectively.

Ryhan's portfolio

Discover all technologies

Oligonucleotide Suppression Of Let-7 Binding By H19 To Reduce Sensitivity To Inflammation

Oligonucleotide compositions targeting H19 enable Let-7 miRNA displacement, reducing inflammation and muscle wasting in tissue.

Management of pre-term labour via an application for pathway selective EP2 agonist

Imperial’s EP2 agonist offers a long-acting, non-inflammatory tocolytic solution for managing pre-term labour effectively.

Methods to scale production of hPSC-derived endothelial cells

Scalable 3D bioreactor method yields stable hPSC-derived endothelial cells, overcoming limitations of 2D culture drift.